Call 911
New or unexplained chest pain or pressure, especially with shortness of breath, sweating, faintness, or pain spreading to your arm, jaw or back. Do not assume it is heartburn.
Understanding PPI Rebound
Planning a medication change with your provider
Talk with the clinician who manages your PPI before reducing the dose, skipping doses, stopping it, or replacing it with another medicine or supplement.
One of the most common questions we hear is whether people can stop taking their acid-suppressing medication. That decision belongs to you and the provider who prescribed it. We can explain why stopping can be harder than expected and help you walk into that appointment prepared.
Why Symptoms Can Return After A Change
Your stomach uses chemical signals to regulate acid production. During PPI treatment, one of those signals, a hormone called gastrin, often rises in response to lower acidity. After treatment is reduced or stopped, the stomach can temporarily produce more acid than it did before.
Clinicians call this rebound acid hypersecretion. It can contribute to heartburn, a sour taste, or upper abdominal discomfort after a medication change. It is a physical response to acid suppression, not a sign of dependence on the medicine.
Not everyone develops noticeable symptoms, and research does not give a reliable recovery timetable for every person on a long-term PPI.
Returning Symptoms Need Interpretation
Symptoms after reducing or stopping a PPI may reflect rebound, ongoing reflux disease, or something else. More than one explanation is possible, and you cannot reliably tell the difference from the burning sensation alone.
Do not assume worsening symptoms mean your body is simply adjusting. Tell your clinician what changed and how you feel.
Why Continued Treatment Sometimes Matters
Your clinician looks beyond how much heartburn you feel. Endoscopy findings, previous complications and bleeding risk all help determine whether continued acid suppression remains important. Barrett's esophagus, severe erosive esophagitis, a previous esophageal ulcer or narrowing, and a high risk of upper digestive tract bleeding are among the reasons treatment often continues even when symptoms improve.
"Feeling better sometimes means the treatment is working. It does not always mean the reason for treatment has gone away."
Questions Worth Asking Your Provider
- Why was my PPI started, and does that reason still apply?
- Do my prior findings or bleeding risk make continued treatment important?
- If you recommend a change, what written plan should I follow?
- What should I do if symptoms return?
- Which symptoms need prompt attention, and when should we follow up?
- Are the supplements I take appropriate with my medicines and medical history?
Bring your medication list, any endoscopy or biopsy reports you have, and a short record of when symptoms occur. Do not skip doses to test yourself.
Habits Worth Discussing
Allow about three hours between your evening meal and bedtime. For nighttime symptoms, ask about raising the head of your bed. If you smoke, seek help quitting. Pay attention to the foods and drinks that repeatedly bring on your symptoms rather than removing everything on a list.
These habits support your care. They do not establish whether it is appropriate to change your treatment.
When To Get Help Quickly
Go to emergency care
Vomiting blood, vomit resembling coffee grounds, or black, tarry stools. If food is stuck and you cannot swallow saliva, seek emergency care.
Contact your clinician promptly
Worsening difficulty swallowing, pain with swallowing, persistent vomiting, or unexplained weight loss. These should not be treated as routine rebound.
Where Re:flux Fits
Re:flux is a dietary supplement formulated with plant polyphenols to support normal digestive function. It is not a medication and is not a substitute for one. If you take prescription medication, talk with your healthcare provider before making any changes to your treatment plan.
For Your Provider
Dr. Brown has prepared a clinical summary and the published research for healthcare professionals.
Sources For This Page
This page draws on published clinical guidelines, peer-reviewed research and information from the following sources.
- Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022;162(4):1334-1342. doi:10.1053/j.gastro.2021.12.247
- Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022;117(1):27-56. Full text · doi:10.14309/ajg.0000000000001538
- Wani S, et al. AGA Clinical Practice Guideline on Surveillance of Barrett's Esophagus. Gastroenterology. Published online October 2025. doi:10.1053/j.gastro.2025.09.012
- National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of GER & GERD . Accessed September 14, 2026.
- American Heart Association. Warning Signs of a Heart Attack . Accessed September 14, 2026.
This information is educational and is not medical advice. Do not start, change or stop any prescription medication without talking to your healthcare provider.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.